FMR LLC 13D and 13G filings for Alnylam Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 14,640,525 11.000% | -2,193,570 (-13.03%) | Filing |
| 2025-11-05 11:26 am Purchase | 2025-09-30 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 16,834,095 12.800% | 2,078,491 (+14.09%) | Filing |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 14,755,604 11.484% | 1,490,226 (+11.23%) | Filing |
| 2024-08-12 09:40 am Purchase | 2024-08-09 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 13,265,378 10.484% | 2,922,981 (+28.26%) | Filing |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 10,342,397 8.239% | -3,200,428 (-23.63%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 13,542,825 11.005% | -4,397,195 (-24.51%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 17,940,020 14.999% | 1,848,075 (+11.48%) | Filing |